Influence of tumor antigen on maintenance versus depression of tumor-specific immunity.
D000818:Animals; D000951:Antigens, Neoplasm / Q000008:administration & dosage; D062109:Dermatologic Surgical Procedures; D003888:Desensitization, Immunologic; D005260:Female; D005354:Fibrosarcoma / Q000139:chemically induced / Q000453:epidemiology / Q000276:immunology* / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D005620:Freund's Adjuvant / Q000008:administration & dosage; D006649:Histocompatibility Antigens / Q000032:analysis; D007114:Immunization; D007165:Immunosuppression Therapy; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D008297:Male; D008748:Methylcholanthrene; D051379:Mice; D008815:Mice, Inbred Strains; D009368:Neoplasm Transplantation; D012513:Sarcoma, Experimental; D013997:Time Factors; D014184:Transplantation, Homologous
D000951:Antigens, Neoplasm; D006649:Histocompatibility Antigens; D008748:Methylcholanthrene; D005620:Freund's Adjuvant